T. Rowe Price Associates
ARDT

T. Rowe Price Associates’s Ardent Health ARDT Stock Holding History

T. Rowe Price Associates’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Buy
40,644
+3,895
+11% +$36.9K ﹤0.01% 2727
2026
Q1 		$315K Buy
36,749
+5,205
+17% +$46.7K ﹤0.01% 2663
2025
Q4 		$279K Hold
31,544
– – ﹤0.01% 2677
2025
Q3 		$418K Buy
31,544
+19,964
+172% +$250K ﹤0.01% 2439
2025
Q2 		$159K Buy
11,580
+1,284
+12% +$17.3K ﹤0.01% 2787
2025
Q1 		$142K Buy
+10,296
New +$150K ﹤0.01% 2748

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's ARDT Position: Q2 2026 in Review

T. Rowe Price Associates increased its Ardent Health (ARDT) stake by 11% in Q2 2026, buying an estimated $36.9K and bringing the position to 40,644 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

T. Rowe Price Associates first reported a position in ARDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $418K in Q3 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • T. Rowe Price Associates held 40,644 shares of Ardent Health worth $400K as of Q2 2026.
  • T. Rowe Price Associates bought 3,895 Ardent Health shares in Q2 2026, an estimated $36.9K.
  • Ardent Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2727 holding.
  • T. Rowe Price Associates first reported a position in Ardent Health in Q1 2025 and has held it in 6 quarters since.
  • T. Rowe Price Associates's Ardent Health position peaked at $418K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.